Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruilong Zhou

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Frontiers in Oncology|May 30, 2024
Construction of diagnostic models for the progression of hepatocellular carcinoma using machine learningXin Jiang, Ruilong Zhou, Fengle Jiang, et al.
Critical Reviews in Oncology/Hematology|April 13, 2026
Human endogenous retroviruses in liver cancer: a double-edged sword in tumor progression and anti-tumor immunityXin Jiang, Zhen Huang, Yang Zhong, et al.
Frontiers in Genetics|August 27, 2021
deepMNN: Deep Learning-Based Single-Cell RNA Sequencing Data Batch Correction Using Mutual Nearest NeighborsBin Zou, Tongda Zhang, Ruilong Zhou, et al.
Advanced Materials (Deerfield Beach, Fla.)|April 26, 2024
Double-Layered Hollow Mesoporous Cuprous Oxide Nanoparticles for Double Drug Sequential Therapy of TumorsZongheng Li, Jing Yang, Bin Ren, et al.
Colloids and Surfaces. B, Biointerfaces|November 11, 2025
Small molecule-stabilized exceedingly small magnetic iron oxide nanoparticles as a contrast agent of T<sub>1</sub>-weighted magnetic resonance imagingRuilong Zhou, Basheng Hu, Guochao Wu, et al.
Biomaterials|September 2, 2023
A STING pathway-activatable contrast agent for MRI-guided tumor immunoferroptosis synergistic therapyShuai Guo, Wei Xiong, Jiaoyang Zhu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 3, 2024
A Turbo-Charging System-Like Contrast Agent for MRI-Guided STING Pathway-Activated Cancer ImmunotherapyBin Ren, Sihua Yan, Zongheng Li, et al.
Small (Weinheim an Der Bergstrasse, Germany)|March 3, 2024
MRI-Guided Tumor Therapy Based on Synergy of Ferroptosis, Immunosuppression Reversal and DisulfidptosisShuai Guo, Zongheng Li, Ruilong Zhou, et al.
Clinical and Translational Medicine|July 15, 2022
Integrating plasma cell-free DNA with clinical laboratory results enhances the prediction of critically ill patients with COVID-19 at hospital admissionYong Bai, Fang Zheng, Tongda Zhang, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Frontiers in Oncology|May 30, 2024
Construction of diagnostic models for the progression of hepatocellular carcinoma using machine learningXin Jiang, Ruilong Zhou, Fengle Jiang, et al.
Critical Reviews in Oncology/Hematology|April 13, 2026
Human endogenous retroviruses in liver cancer: a double-edged sword in tumor progression and anti-tumor immunityXin Jiang, Zhen Huang, Yang Zhong, et al.
Frontiers in Genetics|August 27, 2021
deepMNN: Deep Learning-Based Single-Cell RNA Sequencing Data Batch Correction Using Mutual Nearest NeighborsBin Zou, Tongda Zhang, Ruilong Zhou, et al.
Advanced Materials (Deerfield Beach, Fla.)|April 26, 2024
Double-Layered Hollow Mesoporous Cuprous Oxide Nanoparticles for Double Drug Sequential Therapy of TumorsZongheng Li, Jing Yang, Bin Ren, et al.
Colloids and Surfaces. B, Biointerfaces|November 11, 2025
Small molecule-stabilized exceedingly small magnetic iron oxide nanoparticles as a contrast agent of T<sub>1</sub>-weighted magnetic resonance imagingRuilong Zhou, Basheng Hu, Guochao Wu, et al.
Biomaterials|September 2, 2023
A STING pathway-activatable contrast agent for MRI-guided tumor immunoferroptosis synergistic therapyShuai Guo, Wei Xiong, Jiaoyang Zhu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 3, 2024
A Turbo-Charging System-Like Contrast Agent for MRI-Guided STING Pathway-Activated Cancer ImmunotherapyBin Ren, Sihua Yan, Zongheng Li, et al.
Small (Weinheim an Der Bergstrasse, Germany)|March 3, 2024
MRI-Guided Tumor Therapy Based on Synergy of Ferroptosis, Immunosuppression Reversal and DisulfidptosisShuai Guo, Zongheng Li, Ruilong Zhou, et al.
Clinical and Translational Medicine|July 15, 2022
Integrating plasma cell-free DNA with clinical laboratory results enhances the prediction of critically ill patients with COVID-19 at hospital admissionYong Bai, Fang Zheng, Tongda Zhang, et al.
Pageof 1